Evolution of the Average Target: Bekaert NV

Evolution of the Target Price: Bekaert NV

Changes in Analyst Recommendations: Bekaert NV

10b.Qonb31HNViJldLY486O8XiKrkJC4AMiOcfVB7BPGbIk.KNi-iTv0HG8wEs8PnsrWEhHJ1uXoQq3nKMVxvXiqK-As1qrqPZc1UQcM1Q~b6848dfc9642d208ce330a55824ccc18
31/07 Bekaert: 1H26: BBRG is in trouble Alphavalue
07/07 Bekaert: EPS cut (2026: -10.0%, 2027: -8.4%) Alphavalue
20/05 Bekaert: 1Q26: Benefiting from electrification trends in the US Alphavalue
13/04 Bekaert: EPS cut (2025: -68.1%, 2026: -8.4%) Alphavalue
26/02 Bekaert: FY2025: Resilient results Alphavalue
19/01 Bekaert lowers 2025 EPS on restructuring costs Alphavalue
26/11 AlphaValue/Baader Europe Cuts Earnings Estimates for Bekaert Post Q3 Update MT
25/11 Bekaert trimmed EPS outlook and lower capex support attractive valuation Alphavalue
24/11 Bekaert shows resilient Q3 2025 performance despite weaker demand Alphavalue
31/25/31 Bekaert: Uncertainty pressures sales; cost controls support margin resilience Alphavalue
22/25/22 Correction: AlphaValue/Baader Europe Adjusts Bekaert Estimates MT
21/25/21 Bekaert: EPS cut (2024: -3.0%, 2025: -6.3%) Alphavalue
14/25/14 Bekaert: Solid Q1 performance in line with expectations amid tariff uncertainty Alphavalue
17/25/17 Bekaert: Lower volumes weigh on FY24, FY25 outlook remains challenging Alphavalue
09/25/09 Bekaert: EPS cut (2024: -6.8%, 2025: -1.5%) Alphavalue
04/24/04 Bekaert: Challenging Q3 hit by lower volumes and adverse impact from raw-material costs Alphavalue
24/24/24 Bekaert: Opinion change, from Buy to Reduce Alphavalue
12/24/12 Bekaert: Mixed H1 results: Strong SWS performance, growth segments under pressure Alphavalue
22/24/22 Q1 2024: Some misses, some beats, a few surprises and broadly lofty valuations Alphavalue
11/23/11 Bekaert : CMD takeway: legacy divisions to drive the significance of the growth divisions Alphavalue
20/23/20 Bekaert : Q3 23: volumes have yet to land Alphavalue
02/23/02 Bekaert : Closing FY22 on a strong FCF, 8.8% yield, and acceleration in hydrogen Alphavalue
18/22/18 Bekaert : Q3 22: huge pricing and lower volumes again; a FY22 guidance, at last Alphavalue
16/22/16 Bekaert : Q1 22 figures showed astonishing pricing and weakening volumes Alphavalue
03/22/03 Bekaert : Expectation-beating FY21 results, strong set-up to navigate the crisis Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+2.94%
+21.38%
+4.43%
+4.3%
- - +17.49%
-2.77%
+14.62%
+6.2%
Average +8.57%
Weighted average by Cap. +8.26%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
38.50EUR
Average target price
44.00EUR
Spread / Average Target
+14.29%
High Price Target
55.00EUR
Spread / Highest target
+42.86%
Low Price Target
34.50EUR
Spread / Lowest Target
-10.39%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
A